The cost-effectiveness of routine postoperative radiotherapy after sector resection and axillary dissection for breast cancer stage I: results from a randomized trial

This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. "The cost of routine postoperative radiotherapy after sector resection and axillary dissection in breast cancer stage I per avoided local recurrence and gained QALY is high. The costs per gained QALY show great variation depending on utility value."